|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 101.06 USD | -0.07% |
|
-0.23% | +79.85% |
| Capitalization | 19.18B 16.49B 15.44B 14.39B 26.59B 1,726B 28.92B 181B 69.75B 815B 71.98B 70.44B 2,981B | P/E ratio 2025 * |
-168x | P/E ratio 2026 * | 249x |
|---|---|---|---|---|---|
| Enterprise value | 20.59B 17.7B 16.58B 15.46B 28.55B 1,853B 31.05B 194B 74.9B 875B 77.29B 75.64B 3,201B | EV / Sales 2025 * |
6.38x | EV / Sales 2026 * | 5.51x |
| Free-Float |
98.92% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Exact Sciences Corporation
| 1 day | -0.07% | ||
| 1 week | -0.23% | ||
| Current month | -0.23% | ||
| 1 month | +45.14% | ||
| 3 months | +87.81% | ||
| 6 months | +85.84% | ||
| Current year | +79.85% |
| 1 week | 100.98 |  | 101.43 |
| 1 month | 64.92 | | 101.87 |
| Current year | 38.81 | | 101.87 |
| 1 year | 38.81 | | 101.87 |
| 3 years | 38.81 | | 101.87 |
| 5 years | 29.27 | | 159.54 |
| 10 years | 4.67 | | 159.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kevin Conroy
CEO | Chief Executive Officer | 59 | 2009-03-17 |
Aaron Bloomer
DFI | Director of Finance/CFO | 39 | 2024-04-14 |
Tomasz Beer
CTO | Chief Tech/Sci/R&D Officer | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Kevin Conroy
CHM | Chairman | 59 | 2014-03-20 |
| Director/Board Member | 70 | 2009-04-28 | |
Daniel Levangie
BRD | Director/Board Member | 75 | 2010-07-18 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 6.8% | 1 M€ | +22.67% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.07% | -0.23% | +61.41% | +121.87% | 19.18B | |
| -5.91% | -5.77% | +4.13% | +64.19% | 3.53B | |
| +0.83% | -3.47% | -1.03% | -19.92% | 2.44B | |
| -15.52% | -24.97% | +143.00% | +78.79% | 2.25B | |
| +1.33% | -4.48% | +365.25% | - | 1.06B | |
| -4.53% | +3.69% | -24.98% | +47.89% | 953M | |
| 0.00% | -10.93% | -74.03% | -72.60% | 873M | |
| +0.19% | 0.00% | +13.47% | -11.23% | 805M | |
| -5.37% | +25.57% | - | - | 729M | |
| 0.00% | +2.21% | -27.31% | -72.26% | 537M | |
| Average | -1.39% | -2.19% | +51.10% | +17.09% | 3.24B | |
| Weighted average by Cap. | -0.85% | -2.56% | +57.16% | +85.93% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 3.23B 2.78B 2.6B 2.42B 4.48B 291B 4.87B 30.42B 11.75B 137B 12.12B 11.86B 502B | 3.67B 3.15B 2.95B 2.75B 5.09B 330B 5.53B 34.55B 13.34B 156B 13.77B 13.47B 570B |
| Net income | -112M -96.43M -90.34M -84.2M -156M -10.1B -169M -1.06B -408M -4.77B -421M -412M -17.44B | 80.44M 69.14M 64.77M 60.37M 112M 7.24B 121M 758M 293M 3.42B 302M 295M 12.5B |
| Net Debt | 1.42B 1.22B 1.14B 1.06B 1.96B 127B 2.14B 13.34B 5.15B 60.21B 5.32B 5.2B 220B | 1.03B 889M 832M 776M 1.43B 93.04B 1.56B 9.74B 3.76B 43.94B 3.88B 3.8B 161B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-05 | 101.06 $ | -0.07% | 6,629,240 |
| 25-12-04 | 101.13 $ | -0.12% | 8,957,072 |
| 25-12-03 | 101.25 $ | +0.05% | 6,017,284 |
| 25-12-02 | 101.20 $ | 0.00% | 10,321,968 |
| 25-12-01 | 101.20 $ | -0.09% | 10,600,980 |
Delayed Quote Nasdaq, December 05, 2025 at 04:00 pm EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- EXAS Stock
Select your edition
All financial news and data tailored to specific country editions
